SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-23-047471
Filing Date
2023-06-08
Accepted
2023-06-08 16:10:57
Documents
2
Period of Report
2023-06-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4258
2 POWER OF ATTORNEY ea179971ex24-1_protara.htm EX-24.1 7589
  Complete submission text file 0001213900-23-047471.txt   13373
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Issuer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 508 WRANGLER DRIVE, SUITE 100 COPPELL TX 75019
Business Address
Smith Cynthia (Reporting) CIK: 0001609480 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36694 | Film No.: 231002007